Loading clinical trials...
Loading clinical trials...
PROmyBETAapp: Ascertaining Medication Usage & Documentation of Patient Reported Outcomes Utilizing the myBETAapp® in Patients With Multiple Sclerosis Treated With Betaferon®: a Pilot Study
Conditions
Interventions
Interferon beta-1b (Betaferon, BAY86-5046)
Betaconnect auto-injector
+1 more
Locations
1
Germany
Many locations
Multiple Locations, Germany
Start Date
September 15, 2017
Primary Completion Date
May 9, 2018
Completion Date
May 9, 2018
Last Updated
March 26, 2019
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions